Infection Surveillance in Intensive Care Patients
- Conditions
- InfectionPneumoniaSepsisCross Infection
- Registration Number
- NCT00197847
- Lead Sponsor
- Herlev Hospital
- Brief Summary
Purpose of the study is to investigate and quantify known and possible new riskfactors for nosocomiel infection and death in the intensive care setting.
As new riskfactors Mannose Binding Lechtin and Procalcitonin are chosen and compared to established riskfactors.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 549
Inclusion Criteria
Admission to ICU -
Exclusion Criteria
Absence of informed consent and age less than 18 years
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link Mannose Binding Lectin to nosocomial infection risk in ICU patients?
How does Procalcitonin compare to traditional biomarkers in predicting sepsis outcomes in critical care?
Are there specific ICU biomarkers that improve patient selection for infection risk stratification?
What adverse events are associated with Procalcitonin-based infection monitoring in intensive care units?
How do Mannose Binding Lectin and Procalcitonin correlate with established risk factors for cross infection in hospitals?
Trial Locations
- Locations (1)
Department of Intensive Care
🇩🇰Copenhagen, Copenhagen Couty, Denmark
Department of Intensive Care🇩🇰Copenhagen, Copenhagen Couty, Denmark